SABATINI, SILVIA
SABATINI, SILVIA
Istituto di Fisiologia Clinica - IFC
Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence
2026 Panunzi, S.; Russo, S.; Pompa, M.; De Gaetano, A.; Verrastro, O.; Tuccinardi, D.; Guidone, C.; Gissey, L. C.; Casella, G.; Casella Mariolo, J. R.; Angelini, G.; Pattou, F.; Sabatini, S.; Gastaldelli, A.; Franks, P. W.; Al Ozairi, E.; Sparso, T.; Bornstein, S.; Le Roux, C. W.; Mingrone, G.
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes
2025 Pezzica, Samantha; Pratesi, Filippo; Sabatini, Silvia; Carli, Fabrizia; Mengozzi, Alessandro; Solini, Anna; Gastaldelli, Amalia
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features
2024 Lori, G.; Pastore, M.; Navari, N.; Piombanti, B.; Booijink, R.; Rovida, E.; Tusa, I.; Lewinska, M.; Andersen, J. B.; Lottini, T.; Arcangeli, A.; Taddei, M. L.; Pranzini, E.; Mancini, C.; Anceschi, C.; Madiai, S.; Sacco, E.; Rota, S.; Trapani, A.; Agrimi, G.; Ramazzotti, M.; Ostano, P.; Peraldo Neia, C.; Parri, M.; Carli, F.; Sabatini, S.; Gastaldelli, A.; Marra, F.; Raggi, C.
Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies
2024 Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A.
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss
2024 Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A.
Hepatic glucose metabolism in the steatotic liver
2024 Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A.
Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis
2024 Sabatini, Silvia; Sen, Partho; Carli, Fabrizia; Pezzica, Samantha; Rosso, Chiara; Lembo, Erminia; Verrastro, Ornella; Daly, Ann; Govaere, Olivier; Cockell, Simon; Hyötyläinen, Tuulia; Mingrone, Geltrude; Bugianesi, Elisabetta; Anstee, Quentin M.; Orešič, Matej; Gastaldelli, Amalia
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
2024 Carli, F.; Della Pepa, G.; Sabatini, S.; Vidal Puig, A.; Gastaldelli, A.
On a special class of gibbs hard-core point processes modeling random patterns of non-overlapping grains
2024 Sabatini, Silvia; Villa, Elena
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
2023 Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
2022 Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
2022 Longo, Miriam; Meroni, Marica; Paolini, Erika; Erconi, Veronica; Carli, Fabrizia; Fortunato, Francesco; Ronchi, Dario; Piciotti, Roberto; Sabatini, Silvia; Macchi, Chiara; Alisi, Anna; Miele, Luca; Soardo, Giorgio; Comi, Giacomo Pietro; Valenti, Luca; Ruscica, Massimiliano; Fracanzani, Anna L.; Gastaldelli, Amalia; Dongiovanni, Paola
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
2021 Gastaldelli, A; Sabatini, S; Carli, F; Gaggini, M; Bril, F; Belfortdeaguiar, R; Positano, V; Barb, D; Kadiyala, S; Harrison, S; Cusi, K
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence | 1-gen-2026 | Panunzi, S.; Russo, S.; Pompa, M.; De Gaetano, A.; Verrastro, O.; Tuccinardi, D.; Guidone, C.; Gissey, L. C.; Casella, G.; Casella Mariolo, J. R.; Angelini, G.; Pattou, F.; Sabatini, S.; Gastaldelli, A.; Franks, P. W.; Al Ozairi, E.; Sparso, T.; Bornstein, S.; Le Roux, C. W.; Mingrone, G. | |
| Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes | 1-gen-2025 | Pezzica, Samantha; Pratesi, Filippo; Sabatini, Silvia; Carli, Fabrizia; Mengozzi, Alessandro; Solini, Anna; Gastaldelli, Amalia | |
| Altered fatty acid metabolism rewires cholangiocarcinoma stemness features | 1-gen-2024 | Lori, G.; Pastore, M.; Navari, N.; Piombanti, B.; Booijink, R.; Rovida, E.; Tusa, I.; Lewinska, M.; Andersen, J. B.; Lottini, T.; Arcangeli, A.; Taddei, M. L.; Pranzini, E.; Mancini, C.; Anceschi, C.; Madiai, S.; Sacco, E.; Rota, S.; Trapani, A.; Agrimi, G.; Ramazzotti, M.; Ostano, P.; Peraldo Neia, C.; Parri, M.; Carli, F.; Sabatini, S.; Gastaldelli, A.; Marra, F.; Raggi, C. | |
| Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies | 1-gen-2024 | Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A. | |
| GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss | 1-gen-2024 | Pepa, G. D.; Patricio, B. G.; Carli, F.; Sabatini, S.; Astiarraga, B.; Ferrannini, E.; Camastra, S.; Gastaldelli, A. | |
| Hepatic glucose metabolism in the steatotic liver | 1-gen-2024 | Scoditti, E.; Sabatini, S.; Carli, F.; Gastaldelli, A. | |
| Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis | 1-gen-2024 | Sabatini, Silvia; Sen, Partho; Carli, Fabrizia; Pezzica, Samantha; Rosso, Chiara; Lembo, Erminia; Verrastro, Ornella; Daly, Ann; Govaere, Olivier; Cockell, Simon; Hyötyläinen, Tuulia; Mingrone, Geltrude; Bugianesi, Elisabetta; Anstee, Quentin M.; Orešič, Matej; Gastaldelli, Amalia | |
| Lipid metabolism in MASLD and MASH: From mechanism to the clinic | 1-gen-2024 | Carli, F.; Della Pepa, G.; Sabatini, S.; Vidal Puig, A.; Gastaldelli, A. | |
| On a special class of gibbs hard-core point processes modeling random patterns of non-overlapping grains | 1-gen-2024 | Sabatini, Silvia; Villa, Elena | |
| Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk | 1-gen-2023 | Carli, Fabrizia; Sabatini, Silvia; Gaggini, Melania; Maria Sironi, Anna; Bedogni, Giorgio; Gastaldelli, Amalia | |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals | 1-gen-2022 | Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia | |
| TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models | 1-gen-2022 | Longo, Miriam; Meroni, Marica; Paolini, Erika; Erconi, Veronica; Carli, Fabrizia; Fortunato, Francesco; Ronchi, Dario; Piciotti, Roberto; Sabatini, Silvia; Macchi, Chiara; Alisi, Anna; Miele, Luca; Soardo, Giorgio; Comi, Giacomo Pietro; Valenti, Luca; Ruscica, Massimiliano; Fracanzani, Anna L.; Gastaldelli, Amalia; Dongiovanni, Paola | |
| PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH | 1-gen-2021 | Gastaldelli, A; Sabatini, S; Carli, F; Gaggini, M; Bril, F; Belfortdeaguiar, R; Positano, V; Barb, D; Kadiyala, S; Harrison, S; Cusi, K |